Estrogen replacement therapy and coagulation relationship to lipid and lipoprotein changes

Obstetrical and Gynecological Survey

Volumn 89, Issue 3, 1997, Pages 326-331

  Kessler, Craig M ^a,b   Szymanski, Linda M ^a,b   Shamsipour, Zivar ^a,b   Muesing, Richard A ^a,b   Miller, Valery T ^a,b   Earosa, John C ^a,b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; COMPLEMENT COMPONENT C4B; CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN C; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HEMATOLOGICAL PARAMETERS; HEMOSTASIS; HORMONE SUBSTITUTION; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL;

ADULT; BLOOD COAGULATION; CHOLESTEROL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; LIPOPROTEINS; MIDDLE AGED;

EID: 0031106450     PISSN: 00297828     EISSN: 15339866     Source Type: Journal    
DOI: 10.1080/00006250-199703000-00002     Document Type: Article

References (27)

1. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. JAMA 1995;273:199-208.
2. Ettinger B, Friedman GD, Bush T, Quesenberry CP Jr. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol 1996;87:6-12.
3. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47-63.
4. Miller VT. Lipids, lipoproteins, women and cardiovascular disease. Atherosclerosis 1994;108:S73-S82.
5. Nabulsi A, Folsom AR, White A, Patsch W, Heiss G, Wu KK, et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N Engl J Med 1993;328:1069-75.
6. Sacks FM, McPherson R, Walsh BW. Effect of postmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Intern Med 1994;154:1106-10.
7. Williams JK, Adams MR, Klopfenstein HB. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990;81: 1680-7.
8. Sporrong T, Mattson L., Samsioe G, Stigendal L, Hellgren M. Haemostatic changes during continuous oestradiol-progestogen treatment of postmenopausal women. Br J Obstet Gynaecol 1990; 97:939-44.
9. Notelovitz M, Kitchens CS, Ware MD. Coagulation and fibrinolysis in estrogen-treated surgically menopausal women. Obstet Gynecol 1984;63:621-5.
10. Caine YG, Bauer KA, Barzegar S, ten Cate H, Sacks FM, Walsh BW, et al. Coagulation activation following estrogen administration to postmenopausal women. Thromb Haemost 1992;68:392-5.
11. Brown BG, Zhao X-Q, Sacco DE, Albers JJ. Lipid lowering and plaque regression. New' insights into prevention of plaque disruption and clinical events in coronary disease. Circulation 1993;87: 1781-91.
12. Ludmer PL, Selwin AP, Shook TL, Wayne RR, Mudge GH, Aleander RW, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046-51.
13. Bo M, Bonino F, Neirotti M, Gottero M, Pernigotti L, Molaschi M, et al. Hemorrheologic and coagulative pattern in hypercholester-olemic subjects treated with lipid lowering drugs. Angiology 1991;42:106-13.
14. Cortellaro M, Boschetti C, Cofrancesco E, Zanussi C, Catalano M, de Gaetano G, et al. The PLAT Study: A multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients. Atherosclerosis 1991;90:109-18.
15. Lacoste L, Lam JYT, Hung J, Letchacovski G, Solymoss CB, Waters D. Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction. Circulation 1995;92:3172-7.
16. Rifkind BM, Segal P. Lipid Research Clinics Program reference values for hyperlipidemia and hypolipidemia. JAMA 1983;250: 1869-72.
17. Miller VT, Muesing RA, LaRosa JC, Stoy DB, Phillips EA, Stillman RF. Effects of conjugated equine estrogen with and without three different progestogens on lipoproteins, high-density lipoprotein subfractions, and apolipoprotein A-I. Obstet Gynecol 1991;77:235-40
18. Clauss A. Gerinnungs physiologische Schnell Methode zur Bestim-mung des Fibrinogens. Acta Haematol 1957;17:237-46.
19. Pradelles P, Grassi J, Maclouf J. Enzyme immunoassays of eico-sanoids using acetylcholine esterase as label: An alternative to radioimmunoassay. Anal Chem 1985;57:1170-3.
20. Baginsky ML, Brown WV. A new' method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase. J Lipid Res 1979;20:548-56.
21. Devor M, Barrett-Connor E, Renvall M, Feigal D, Ramsdell J. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 1992;92:275-82.
22. Daly E, Vessey MP, Hawkins MM, Carson JL, Gough P, Marsh S. Risk of venous thromboembolism in users of hormone replacement therapy. Lancet 1996;348:977-80.
23. Kannel WB. Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study. Am Heart J 1987;114:413-9.
24. Alkjaersig N, Fletcher AP, deZiegler D, Steingold KA, Meldrum DR, Judd HL. Blood coagulation in postmenopausal women given estrogen treatment: Comparison of transdermal and oral administration. J Lab Clin Med 1988;111:224-8.
25. Rodgers GM, Chandler WL. Laboratory and clinical aspects of inherited thrombotic disorders. Am J Hematol 1992;41:113-22.
26. De Souza MJ, Nulsen JC, Sequenzia LC, Bona RD, Walker FJ, Luciano AA. The effects of medroxyprogesterone acetate on conjugated equine estrogen-induced changes in coagulation parameters in postmenopausal women. J Women Health 1996;5:121-8.
27. von Kaulla E, Droegemueller W, von Kaulla KN. Conjugated estrogens and hypercoagulability. Am J Obstet Gynecol 1975;122: 688-2.